~~<i id='9D2D88FEDF'><strike id='9D2D88FEDF'><tt id='9D2D88FEDF'><pre id='9D2D88FEDF'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：entertainment 2025-09-29 08:07:07 Page View：66828

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Lilly's Alzheimer's drug donanemab backed by FDA advisers
Next article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

comprehensive

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Cigna wins case to block Amy Bricker's move to CVS

AdobeCVSHealthviewedAmyBrickerasapotentialCEO.Butshewon’tbegoingtothehealthcareconglomerateanytimeso

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

FDA reviewers ask if approval of Lilly’s Alzheimer’s drug should be restricted

DarronCummings/APScientistsattheFoodandDrugAdministrationhavetwobigquestionsaboutEliLilly’sexperimen